ELUT
ELUTIA INC.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Jan 30 ▲ 2 insiders buy $95.0K at $1.06
- Mar 11 Elutia reported its 2025 financial results, highlighted by the $88 m…
- Aug 14 ▲ Short interest falls 34.8% to 25.9K
- Aug 31 ▲ Short interest falls 34.5% to 16.9K
- Sep 15 ▲ Short interest falls 51.5% to 8.2K
- Oct 15 ▼ Short interest jumps 63.8% to 15.3K
- Oct 30 ▼ Short interest jumps 119.6% to 33.7K
- Nov 5 ▲ Earnings: ELUT Q3 2026 Earnings: EPS $-0.14 (+8.5% vs est)
Signal stack
Where each data set points today.
- InsidersBULLISH
2 insiders bought $95.0K at an average $1.06. No open-market sales. Price is 22% below their cost.
- InstitutionsMIXED
Q3 2026: 2 added (0 new), 1 trimmed or exited.
- EstimatesFALLING
Current-quarter EPS estimate −$0.130 → −$0.160 over 90 days. 0 up, 1 down in 30 days.
- Short sellersBUILDING
Short interest +119.6% to 33.7K shares. 1.0 days to cover, ≈0.1% of shares.
- TrendUPTREND
1% above its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | TRIM | $88.0K |
| JANE STREET GROUP, LLC | ADD | $48.9K |
| UBS Group AG | DOUBLED | $1.8K |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | $197.7K |
| VANGUARD FIDUCIARY TRUST CO | ADD | $169.0K |
| BlackRock, Inc. | ADD | $164.4K |
| JANE STREET GROUP, LLC | TRIM | $43.8K |
| NORTHERN TRUST CORP | ADD | $43.8K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Sep 2025Price is below the lowest target. Median implies +508%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Sep 10, 2025 | Lake Street MAINTAIN | Buy |
| May 9, 2025 | Lake Street MAINTAIN | Buy |
| Mar 7, 2025 | Cantor Fitzgerald REITERATE | Overweight |
| Nov 15, 2024 | Cantor Fitzgerald REITERATE | Overweight |
| Sep 6, 2024 | Cantor Fitzgerald REITERATE | Overweight |
| Aug 8, 2024 | Cantor Fitzgerald MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Colpman David Director Nov 10, 2026 | AWARD | 117,000 sh |
Ferguson Matthew CHIEF FINANCIAL OFFICER Nov 10, 2026 | AWARD | 446,000 sh |
Mills C Randal PRESIDENT AND CEO Nov 10, 2026 | AWARD | 895,000 sh |
NEELS GUIDO J Director Nov 10, 2026 | AWARD | 117,000 sh |
RAKIN KEVIN Director Nov 10, 2026 | AWARD | 176,000 sh |
Makes Brigid Director Nov 10, 2026 | AWARD | 117,000 sh |
Williams Michelle LeRoux CHIEF SCIENTIFIC OFFICER Nov 10, 2026 | AWARD | 446,000 sh |
Mills C Randal PRESIDENT AND CEO Sep 10, 2026 | EXERCISE | 27,083 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.16 | -$0.16–-$0.16 | -23.1% | $1.0M |
| Next Q | -$0.15 | -$0.15–-$0.15 | No data | $0.00 |
| Current FY | -$0.66 | -$0.66–-$0.66 | -4.8% | $7.5M |
| Next FY | -$0.63 | -$0.63–-$0.63 | -16.7% | $4.3M |
Short side
FINRA· Oct 30, 2026SecBot reports
7 filings · 0 bullish · 0 bearish · 1 mixed · 6 neutral- NEUTRAL PRESS-RELEASENov 5, 2026
Elutia reported Q3 2026 net sales of $1.1M (+20.4% YoY) but net loss from continuing operations…
Monitor NXT-41 FDA clearance decision in Q4 2026 and NXT-41x FDA submission; the $26M non-dilutive capital provides runway through early commercialization, but the widening operating loss and…
- NEUTRAL 8-KNov 5, 2026
Elutia reported Q3 2026 net sales of $1.1M (+20.4% YoY) but a net loss from continuing operations…
The key catalyst is the NXT-41 FDA clearance decision expected in Q4 2026 and the NXT-41x FDA submission in the same quarter. Monitor for FDA decisions and any Cardiovascular business transaction…
- NEUTRAL PRESS-RELEASEOct 22, 2026
Elutia Inc. announced it will report its Q3 2026 results on November 5, 2026.
- NEUTRAL PRESS-RELEASEJul 31, 2026
Elutia Inc. announced it will report its Q2 2026 results on August 13, 2026.
All ELUT filing & press-release reports (7)
- PRESS-RELEASE reportNov 5, 2026
- 8-K reportNov 5, 2026
- PRESS-RELEASE reportOct 22, 2026
- PRESS-RELEASE reportJul 31, 2026
- 8-K reportJun 16, 2026
- 8-K reportMay 14, 2026
- 8-K reportMar 11, 2026